Souha Hosam Youssef

Dr. Souha Hosam Youssef

University of South Australia, Adelaide, South Australia, Australia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
FAFranklin Afinjuomo
Franklin Afinjuomo
SASADIKALMAHDI HUSSEN ABDELLA
SADIKALMAHDI HUSSEN ABDELLA
SYSouha Hosam Youssef
Souha Hosam Youssef
YSYunmei Song
Yunmei Song
Sanjay GargSanjay Garg
Sanjay Garg
Inulin’s unique and flexible structure, stabilization/protective effects, and organ targeting ability make it an excellent drug delivery carrier compared to other biodegradable polysaccharides. The three hydroxyl groups attached to each fructose unit serve as an anchor for chemical modification. This, in turn, helps in increasing bioavailability, improving cellular uptake, and achieving targeted, sustained, and controlled release of drugs and biomolecules. This review focuses on the various types of inulin drug delivery systems such as hydrogel, conjugates, nanoparticles, microparticles, micelles, liposomes, complexes, prodrugs, and solid dispersion. The preparation and applications of the different inulin drug delivery systems are further discussed. This work highlights the fact that modification of inulin allows the use of this polymer as multifunctional scaffolds for different drug delivery systems.

21 September 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SASADIKALMAHDI HUSSEN ABDELLA
SADIKALMAHDI HUSSEN ABDELLA
SYSouha Hosam Youssef
Souha Hosam Youssef
FAFranklin Afinjuomo
Franklin Afinjuomo
YSYunmei Song
Yunmei Song
PFParis Fouladian
Paris Fouladian
Sanjay GargSanjay Garg
Sanjay Garg
Three-dimensional (3D) printing is among the rapidly evolving technologies with applications in many sectors. The pharmaceutical industry is no exception, and the approval of the first 3D-printed tablet (Spiratam®) marked a revolution in the field. Several studies reported the fabrication of different dosage forms using a range of 3D printing techniques. Thermosensitive drugs compose a considerable segment of available medications in the market requiring strict temperature control during processing to ensure their efficacy and safety. Heating involved in some of the 3D printing technologies raises concerns regarding the feasibility of the techniques for printing thermolabile drugs. Studies reported that semi-solid extrusion (SSE) is the commonly used printing technique to fabricate thermosensitive drugs. Digital light processing (DLP), binder jetting (BJ), and stereolithography (SLA) can also be used for the fabrication of thermosensitive drugs as they do not involve heating elements. Nonetheless, degradation of some drugs by light source used in the techniques was reported. Interestingly, fused deposition modelling (FDM) coupled with filling techniques offered protection against thermal degradation. Concepts such as selection of low melting point polymers, adjustment of printing parameters, and coupling of more than one printing technique were exploited in printing thermosensitive drugs. This systematic review presents challenges, 3DP procedures, and future directions of 3D printing of thermo-sensitive formulations.

10 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Ruixiu LiRuixiu Li
Ruixiu Li
Yu Huan TingYu Huan Ting
Yu Huan Ting
SYSouha Hosam Youssef
Souha Hosam Youssef
YSYunmei Song
Yunmei Song
Sanjay GargSanjay Garg
Sanjay Garg
As a variety of novel technologies, 3D printing has been considerably applied in the field of health care, including cancer treatment. With its fast prototyping nature, 3D printing could transform basic oncology discoveries to clinical use quickly, speed up and even revolutionise the whole drug discovery and development process. This literature review provides insight into the up-to-date applications of 3D printing on cancer research and treatment, from fundamental research and drug discovery to drug development and clinical applications. These include 3D printing of anticancer pharmaceutics, 3D-bioprinted cancer cell models and customised nonbiological medical devices. Finally, the challenges of 3D printing for cancer applications are elaborated, and the future of 3D-printed medical applications is envisioned.

24 February 2023 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
SYSouha Hosam Youssef
Souha Hosam Youssef
SKSangseo Kim
Sangseo Kim
RKRiya Khetan
Riya Khetan
FAFranklin Afinjuomo
Franklin Afinjuomo
YSYunmei Song
Yunmei Song
Sanjay GargSanjay Garg
Sanjay Garg

25 April 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SYSouha Hosam Youssef
Souha Hosam Youssef
SASADIKALMAHDI HUSSEN ABDELLA
SADIKALMAHDI HUSSEN ABDELLA
Sanjay GargSanjay Garg
Sanjay Garg
Technological advancements have created infinite opportunities and rendered our life easier at several fronts. Nonetheless, the environment has suffered the aftermaths of modernization. Ironically, the pharmaceutical industry was found to be a significant contributor to environmental deterioration. To tackle this issue, continuous eco-evaluation of newly introduced technologies is crucial. Three-dimensional printing (3DP) is rapidly establishing its routes in different industries. Interestingly, 3DP is revolutionising the production of pharmaceuticals and is regarded as a promising approach for the fabrication of patient-centric formulations. Despite the increasing applications in the pharmaceutical field, tools that evaluate the environmental impacts of 3DP are lacking. Energy and solvent consumption, waste generation, and disposal are the main associated factors that present major concerns. For the first time, we are proposing a quantitative tool, the index of Greenness Assessment of Printed Pharmaceuticals (iGAPP), that evaluates the greenness of the different 3DP technologies used in the pharmaceutical industry. The tool provides a colour-coded pictogram and a numerical score indicating the overall greenness of the employed printing method. Validation was performed by constructing the greenness profile of selected formulations produced using the different 3DP techniques. This tool is simple to use and indicates the greenness level of the procedures involved, thereby creating an opportunity to modify the processes for more sustainable practices.

6 January 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
SYSouha Hosam Youssef
Souha Hosam Youssef
RGRaja Ganesan
Raja Ganesan
MAMarzieh Amirmostofian
Marzieh Amirmostofian
SKSangseo Kim
Sangseo Kim
RPRuhi Polara
Ruhi Polara
Sanjay GargSanjay Garg
Sanjay Garg
Adjuvant chemotherapy is highly recommended for liver cancer to enhance survival rates due to its tendency to recur frequently. Localized drug-eluting implants have gained traction as an alternative to overcome the limitations of systemic chemotherapy. This work describes the development of biodegradable 3D printed (3DP) bilayer films loaded with 5-fluorouracil (5FU) and cisplatin (Cis) with different infill percentages where the 5FU layers were 40%, 30%, and 30% and Cis layers were 10%, 15%, and 10% for films A, B, and C, respectively. The relevant characterization tests were performed, and the drug content of films was 0.68, 0.50, and 0.50 mg of 5FU and 0.39, 0.80, and 0.34 mg of Cis for films A, B, and C, respectively. Cis release was affected by the alterations to the film design, where films A, B, and C showed complete release at 12, 14, and 23 days, respectively. However, 5FU was released over 24 hours for all films. The films were stable for up to two weeks after storage at 25°C/65% relative humidity and four weeks at 4οC where drug content, tensile strength, FTIR, and thermal analysis results demonstrated negligible alterations. The cytotoxicity of the films was assessed by MTS assays using HepG2 cell lines demonstrating up to 81% reduction in cell viability compared to blank films. Moreover, apoptosis was confirmed by Western Blots and the determination of mitochondrial cell potential, highlighting the potential of these films as a promising approach in adjuvant chemotherapy.